Preliminary scientific studies suggest conolidine may possibly inhibit specific ion channels, reducing neuronal excitability and limiting discomfort signals. This mechanism is especially pertinent in neuropathic suffering, where by abnormal signaling leads to persistent discomfort. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to pain pe... https://collinso470qja4.daneblogger.com/profile